Modelling human liver fibrosis in the context of non-alcoholic steatohepatitis using a microphysiological system

QR Code

Modelling human liver fibrosis in the context of non-alcoholic steatohepatitis using a microphysiological system

Kostrzewski et al. introduce an in vitro microphysiological model of non-alcoholic steatohepatitis (NASH), consisting of co-cultured primary human liver cells. The authors characterised the transcriptomic, inflammatory and fibrotic phenotype of the model and show that major features of NASH can be r...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Tomasz Kostrzewski, Sophie Snow, Anya Lindström Battle, Samantha Peel, Zahida Ahmad, Jayati Basak, Manasa Surakala, Aurelie Bornot, Julia Lindgren, Maria Ryaboshapkina, Maryam Clausen, Daniel Lindén, Christian Maass, Lucy May Young, Adam Corrigan, Lorna Ewart, David Hughes
Format:	article
Langue:	EN
Publié:	Nature Portfolio 2021
Sujets:	Biology (General) QH301-705.5
Accès en ligne:	https://doaj.org/article/2fe033487d4045ff86e6fb36c7f3e8b7
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

A Novel Microphysiological Colon Platform to Decipher Mechanisms Driving Human Intestinal PermeabilitySummary
par: Athanasia Apostolou, et autres
Publié: (2021)

Establishing quasi-steady state operations of microphysiological systems (MPS) using tissue-specific metabolic dependencies
par: Christian Maass, et autres
Publié: (2018)

A combined microphysiological-computational omics approach in dietary protein evaluation
par: Paulus G. M. Jochems, et autres
Publié: (2020)

Modeling early stage atherosclerosis in a primary human vascular microphysiological system
par: Xu Zhang, et autres
Publié: (2020)

Three dimensional and microphysiological bone marrow models detect in vivo positive compounds
par: Rhiannon David, et autres
Publié: (2021)

Statins in Non-alcoholic Steatohepatitis
par: Jose D. Torres-Peña, et autres
Publié: (2021)

An Immunocompetent Microphysiological System to Simultaneously Investigate Effects of Anti-Tumor Natural Killer Cells on Tumor and Cardiac Microtissues
par: Oanh T. P. Nguyen, et autres
Publié: (2021)

Bridging the gap between in silico and in vivo by modeling opioid disposition in a kidney proximal tubule microphysiological system
par: Tomoki Imaoka, et autres
Publié: (2021)

Association between Equol Production Status and Nonalcoholic Steatohepatitis
par: Takemi Akahane, et autres
Publié: (2021)

Cathepsin D regulates lipid metabolism in murine steatohepatitis
par: Tom Houben, et autres
Publié: (2017)

Coculture with hiPS-derived intestinal cells enhanced human hepatocyte functions in a pneumatic-pressure-driven two-organ microphysiological system
par: Marie Shinohara, et autres
Publié: (2021)

Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
par: Justine Gillard, et autres
Publié: (2022)

Inhibition of connexin hemichannels alleviates non-alcoholic steatohepatitis in mice
par: Joost Willebrords, et autres
Publié: (2017)

NEALKOHOLNI STEATOHEPATITIS PRI OTROKU − PRAKTIČNI PRISTOP S PREDSTAVITVIJO PRIMERA
par: Ana Šinkovec, et autres
Publié: (2021)

Loss of SNORA73 reprograms cellular metabolism and protects against steatohepatitis
par: Arthur C. Sletten, et autres
Publié: (2021)

The development of nonalcoholic steatohepatitis is subjected to breeder dependent variation in guinea pigs
par: D. H. Ipsen, et autres
Publié: (2021)

MUTYH is associated with hepatocarcinogenesis in a non-alcoholic steatohepatitis mouse model
par: Hiroki Sakamoto, et autres
Publié: (2021)

β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model
par: Zigmond E, et autres
Publié: (2014)

Treatment of nonalcoholic steatohepatitis with vitamins E and C: a pilot study
par: Kawanaka M, et autres
Publié: (2013)

NON-ALCOHOLIC STEATOHEPATITIS IN CHILDREN − A PRACTICAL APPROACH WITH CASE REPORT
par: Ana Šinkovec, et autres
Publié: (2021)

MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis
par: Huang J, et autres
Publié: (2021)

Clodronate, an inhibitor of the vesicular nucleotide transporter, ameliorates steatohepatitis and acute liver injury
par: Nao Hasuzawa, et autres
Publié: (2021)

Use of GP73 in the diagnosis of non-alcoholic steatohepatitis and the staging of hepatic fibrosis
par: Yadi Li, et autres
Publié: (2021)

Endoscopic duodenal mucosal resurfacing for nonalcoholic steatohepatitis (NASH): a pilot study
par: Alia Hadefi, et autres
Publié: (2021)

Cargo proteins in extracellular vesicles: potential for novel therapeutics in non-alcoholic steatohepatitis
par: Jimin Kim, et autres
Publié: (2021)

Severity of non-alcoholic steatohepatitis is not linked to testosterone concentration in patients with type 2 diabetes.
par: Kristin Alexandra Dayton, et autres
Publié: (2021)

CD4 derived double negative T cells prevent the development and progression of nonalcoholic steatohepatitis
par: Guangyong Sun, et autres
Publié: (2021)

The incidence trends of liver cirrhosis caused by nonalcoholic steatohepatitis via the GBD study 2017
par: Mimi Zhai, et autres
Publié: (2021)

Author Correction: Loss of SNORA73 reprograms cellular metabolism and protects against steatohepatitis
par: Arthur C. Sletten, et autres
Publié: (2021)

Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis
par: Daniel Cabrera, et autres
Publié: (2017)

Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice
par: Kook Hwan Kim, et autres
Publié: (2018)

Rat model of nonalcoholic steatohepatitis created by methionine and choline deficiency: biochemical and histological analyses
par: Seki A, et autres
Publié: (2011)

Quantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis
par: Philip A. Waghorn, et autres
Publié: (2021)

Priming, Triggering, Adaptation and Senescence (PTAS): A Hypothesis for a Common Damage Mechanism of Steatohepatitis
par: Peter M. Abuja, et autres
Publié: (2021)

Dual-specificity phosphatase 3 deletion promotes obesity, non-alcoholic steatohepatitis and hepatocellular carcinoma
par: Sophie Jacques, et autres
Publié: (2021)

Dietary cholesterol promotes steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and calcium signaling
par: Jessie Qiaoyi Liang, et autres
Publié: (2018)

β-Cryptoxanthin alleviates diet-induced nonalcoholic steatohepatitis by suppressing inflammatory gene expression in mice.
par: Masuko Kobori, et autres
Publié: (2014)

Liver sphingomyelin synthase 1 deficiency causes steatosis, steatohepatitis, fibrosis, and tumorigenesis: An effect of glucosylceramide accumulation
par: Zhiqiang Li, et autres
Publié: (2021)

Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease
par: Tae Hyung Kim, et autres
Publié: (2021)

Abdominal subcutaneous fat thickness and homeostasis model assessment of insulin resistance as simple predictors of nonalcoholic steatohepatitis
par: Hegazy MA, et autres
Publié: (2019)